The class I PI3K/Akt pathway is critical for cancer cell survival in dogs and offers an opportunity for therapeutic intervention

被引：0
|
作者：
Yu-Ting Chen
Karen AL Tan
Lisa Y Pang
David J Argyle
机构：
[1] University of Edinburgh,Royal (Dick) School of Veterinary Studies and the Roslin Institute
来源：
BMC Veterinary Research | / 8卷
关键词：
Canine; Cancer; PI3; AKT; MTOR; Therapeutic; Target;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] The class I PI3K/Akt pathway is critical for cancer cell survival in dogs and offers an opportunity for therapeutic intervention
    Chen, Yu-Ting
    Tan, Karen A. L.
    Pang, Lisa Y.
    Argyle, David J.
    BMC VETERINARY RESEARCH, 2012, 8
  • [2] The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications
    Carnero, Amancio
    Blanco-Aparicio, Carmen
    Renner, Oliver
    Link, Wolfgang
    Leal, Juan F. M.
    CURRENT CANCER DRUG TARGETS, 2008, 8 (03) : 187 - 198
  • [3] The PI3K/AKT/mTOR Pathway as a Therapeutic Target in Endometrial Cancer
    Slomovitz, Brian M.
    Coleman, Robert L.
    CLINICAL CANCER RESEARCH, 2012, 18 (21) : 5856 - 5864
  • [4] The PI3K/AKT/mTOR pathway as a therapeutic target in ovarian cancer
    Mabuchi, Seiji
    Kuroda, Hiromasa
    Takahashi, Ryoko
    Sasano, Tomoyuki
    GYNECOLOGIC ONCOLOGY, 2015, 137 (01) : 173 - 179
  • [5] PI3K/Akt signalling pathway and cancer
    Vara, JAF
    Casado, E
    de Castro, J
    Cejas, P
    Belda-Iniesta, C
    González-Barón, M
    CANCER TREATMENT REVIEWS, 2004, 30 (02) : 193 - 204
  • [6] Inhibitors of the PI3K/Akt/mTOR Pathway in Prostate Cancer Chemoprevention and Intervention
    Roudsari, Nazanin Momeni
    Lashgari, Naser-Aldin
    Momtaz, Saeideh
    Abaft, Shaghayegh
    Jamali, Fatemeh
    Safaiepour, Pardis
    Narimisa, Kiyana
    Jackson, Gloria
    Bishayee, Anusha
    Rezaei, Nima
    Abdolghaffari, Amir Hossein
    Bishayee, Anupam
    PHARMACEUTICS, 2021, 13 (08)
  • [7] PI3K/AKT/mTOR signaling pathway as a therapeutic target for ovarian cancer
    Li, HaiXia
    Zeng, JianFang
    Shen, Keng
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2014, 290 (06) : 1067 - 1078
  • [8] Expanding therapeutic targets in bladder cancer: the PI3K/Akt/mTOR pathway
    Ching, Christina Barbara
    Hansel, Donna Elizabeth
    LABORATORY INVESTIGATION, 2010, 90 (10) : 1406 - 1414
  • [9] The PI3K/Akt/mTOR pathway in ovarian cancer: therapeutic opportunities and challenges
    Cheaib, Bianca
    Auguste, Aurelie
    Leary, Alexandra
    CHINESE JOURNAL OF CANCER, 2015, 34 (01) : 4 - 16
  • [10] PI3K/AKT/mTOR signaling pathway as a therapeutic target for ovarian cancer
    HaiXia Li
    JianFang Zeng
    Keng Shen
    Archives of Gynecology and Obstetrics, 2014, 290 : 1067 - 1078
12345